Pharmaceuticals · medium ·
Pharma is moving autonomous AI agents into R&D and medical work
The pharmaceutical industry is accelerating its adoption of autonomous AI agents, shifting from human-assisted 'copilot' roles to independent hypothesis generation and experimental execution in R&D. Concurrently, medical communications are transitioning to dynamic, autonomous agent orchestration for tailored HCP engagement, necessitating robust cybersecurity frameworks to counter new AI-specific threats.
Part of the Healthcare & Life Sciences Opportunity Outlook, Korim's monthly analysis of emerging opportunities in this sector.